Parallel Advisors, LLC Zai Lab LTD Transaction History

Parallel Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$27.77 - $64.4 $18,689 - $43,341	-673 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$54.9 - $105.21 $18,281 - $35,034	333 Added 97.94%	673 $42,000
Q3 2021 Nov 02, 2021	BUY	$105.0 - $178.37 $1,890 - $3,210	18 Added 5.59%	340 $36,000
Q2 2021 Aug 06, 2021	BUY	$125.11 - $180.0 $2,001 - $2,880	16 Added 5.23%	322 $57,000
Q1 2021 Apr 23, 2021	BUY	$126.27 - $191.71 $13,005 - $19,746	103 Added 50.74%	306 $41,000
Q4 2020 Feb 02, 2021	BUY	$81.94 - $135.34 $1,720 - $2,842	21 Added 11.54%	203 $27,000
Q3 2020 Oct 27, 2020	BUY	$73.3 - $89.48 $5,131 - $6,263	70 Added 62.5%	182 $15,000
Q2 2020 Jul 16, 2020	SELL	$48.82 - $82.53 $46,037 - $77,825	-943 Reduced 89.38%	112 $9,000
Q1 2020 Apr 27, 2020	BUY	$39.1 - $62.9 $860 - $1,383	22 Added 2.13%	1,055 $54,000
Q2 2019 Aug 05, 2019	BUY	$25.73 - $35.79 $26,579 - $36,971	1,033 New	1,033 $36,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.66B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.